CareCapital Group plc
11 December 2006
For release at 0700h, 11 December 2006
CareCapital Group Plc
("CareCapital" or "the Company")
Investment and Development Programme in Germany
CareCapital Group Plc, the healthcare real estate company which listed on AIM in
August (CARE), announces that it has completed the acquisition of a major
medical centre in Berlin as the first part of an initial €35 million investment
and development programme in Germany.
This first investment, at an acquisition cost of € 9.2 million, is a 4,100 sq m
medical facility housing 34 tenants including physicians, dentists, a dental
lab, diagnostic facilities, a pharmacy and other healthcare related retailers.
An additional €4.2 million acquisition of a 2,800 sq m medical centre housing 25
medical tenants situated to the South East of Berlin together with its adjoining
development site is scheduled for completion in February 2007.
These two investments represent the initial stage of the €35 million programme,
on which heads of terms have been agreed with a German developer/construction
company, with funding supplied by a major German bank. The programme currently
includes two further development sites in the Berlin area. Any additional
funding for the programme will come from the Company's existing resources and
facilities.
The programme enables CareCapital to capitalise on recent changes in German
legislation which favour primary care provision from large, integrated medical
care centres.
Michael Sinclair, Chairman, commented: "The investment and development programme
in Germany follows extensive research, conducted by CareCapital over the past
months and represents an exciting opportunity for the Company. It will not
impact on our development programme in the UK which remains on target.
"CareCapital will leverage its UK experience to manage and develop the mixed
economy healthcare facilities in Germany that will increasingly become a feature
of UK primary care provision as services are moved out of the hospital
environment to community locations in accordance with Government policy. In
addition, the programme will bring us high quality assets at yields
significantly greater than those currently prevailing in the UK and with
similarly comparable covenant profiles."
For further information please visit www.carecapital.co.uk or contact:
CareCapital Group Plc Daniel Stewart & Co. Plc Tavistock Communications
Paul Stacey, Managing Director Lindsay Mair, Director - Simon Hudson,
Shareen Courtney, Marketing Corporate Finance Richard Sunderland
Tel: 020 7034 1949 Tel: 020 7776 6550 Tel: 020 7920 3150
pstacey@carecapital.co.uk lindsay.mair@danielstewart.co.uk shudson@tavistock.co.uk
scourtney@carecapital.co.uk rsunderland@tavistock.co.uk
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.